BIIB017
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for BIIB017, covering 2014-06-02 to 2014-09-15. Get the full timeline:
Most recent: Clinical Trial Update: Using Optical Coherence Tomography (OCT) to Evaluate the Efficacy and Safety of PEGylated Interferon Beta-1a (BIIB017) in Patients With Relapsing Multiple Sclerosis [Phase 3]